Undisclosed DLL3/CD70 dual CAR T
/ Allogene Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 02, 2026
Off-the-shelf DLL3/CD70 dual CAR T cells with optimized site-specific integration for SCLC and neuroendocrine tumors
(SITC 2026)
- No abstract available
CAR T-Cell Therapy • Lung Cancer • Neuroendocrine Tumor • Oncology • Small Cell Lung Cancer • Solid Tumor • CD70 • DLL3
1 to 1
Of
1
Go to page
1